Periasamy Selvaraj, Ph.D.
page-template,page-template-full_width,page-template-full_width-php,page,page-id-308,qode-social-login-1.1.3,qode-restaurant-1.1.1,stockholm-core-1.1,select-theme-ver-5.1.8,ajax_fade,page_not_loaded,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Periasamy Selvaraj, Ph.D.

Chief Scientific Officer

Dr. Selvaraj completed his postdoctoral training at the Dana Farber Cancer Institute at Harvard Medical School, then served on the faculty of Harvard University as an Instructor from 1988-1990. He moved to Emory University in 1990 as an Assistant Professor ultimately becoming an Associate Professor with tenure. Dr Selvaraj’s accomplishments include:

  • A career as a Professor of Pathology in the School of Medicine since 2010
  • Co-authoring more than 90 research articles in leading scientific journals
  • Developing and investigating several novel immunotherapies for the treatment of cancer
  • Developing new receptor and antibody-based therapies to treat autoimmune diseases such as arthritis